共 236 条
[1]
Younossi ZM(2016)Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-84
[2]
Koenig AB(2016)EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease J Hepatol 64 1388-1402
[3]
Abdelatif D(2019)The epidemiology, risk profiling and diagnostic challenges of nonalcoholic fatty liver disease Medicines (Basel) 6 41-19
[4]
Fazel Y(2009)Non alcoholic fatty liver disease and metabolic syndrome Hippokratia 13 9-910
[5]
Henry L(2016)Bidirectional relationships and disconnects between NAFLD and features of the metabolic syndrome Int J Mol Sci 17 367-90e1
[6]
Wymer M(2014)Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome Lancet Diabetes Endocrinol 2 901-2204
[7]
Iqbal U(2012)Serum levels of alanine aminotransferase decrease with age in longitudinal analysis Clin Gastroenterol Hepatol 10 285-82
[8]
Perumpail BJ(2005)Correlation between serum alanine aminotransferase activity and age: an inverted U curve pattern Am J Gastroenterol 100 2201-79
[9]
Akhtar D(2006)The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999–2002 Am J Gastroenterol 101 76-45
[10]
Kim D(2003)Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States Gastroenterology 124 71-224